Cell Biotech is participating in Vitafoods Asia 2026, which is being held from September 2 to 4 at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand. At the exhibition, Cell Biotech will operate an independent booth to showcase its proprietary probiotic technologies and targeted product portfolio to global buyers, while exploring new business opportunities through the discovery of new partners and expansion into the Asian market. Cell Biotech is currently available in...

Cell Biotech, Korea’s No. 1 probiotic exporter for 13 consecutive years, has made its first-ever export of its proprietary CBT probiotics to South Africa, marking the company’s entry into the African market for the first time since its founding. With this milestone, Cell Biotech has expanded its export footprint beyond Europe, Asia, North America, South America, and Oceania to Africa, completing its global export network across all six continents. The latest export deal was made possible...

Cell Biotech continued its solid growth in the second quarter of 2026, with both sales and operating profit increasing on the back of strong domestic market performance and expanded exports. Cell Biotech reported preliminary second-quarter results of KRW 15.8 billion in sales, KRW 1.6 billion in operating profit, and KRW 3.6 billion in net income. Compared with the same period last year, sales increased by 32.8% and operating profit by 28.0%. For the first half of the year, cumulative sales...